Collegium Pharmaceutical Inc (COLL) — Cash Flow Quality Index
Collegium Pharmaceutical Inc (COLL) has a Cash Flow Quality Index of 2.49x as of September 2025. Operating cash flow of $78.44 Million exceeds net income of $31.51 Million, indicating high earnings quality where cash backs reported profits. Also explore Collegium Pharmaceutical Inc total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Collegium Pharmaceutical Inc Cash Flow Quality Index (2020–2024)
Historical Cash Flow Quality Index for Collegium Pharmaceutical Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Collegium Pharmaceutical Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Collegium Pharmaceutical Inc (2020–2024)
Year-by-year earnings quality comparison for Collegium Pharmaceutical Inc. For live market cap and the full company financial profile, see COLL stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.96x | $204.98 Million | $69.19 Million | ▼ -48.1% |
| 2023 | 5.71x | $274.75 Million | $48.16 Million | ▲ +294.0% |
| 2021 | 1.45x | $103.56 Million | $71.52 Million | ▼ -58.8% |
| 2020 | 3.51x | $93.94 Million | $26.75 Million | — |